Receptors, Prostaglandin E
"Receptors, Prostaglandin E" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors which bind prostaglandins with a high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin E receptors prefer prostaglandin E2 to other endogenous prostaglandins. They are subdivided into EP1, EP2, and EP3 types based on their effects and their pharmacology.
| Descriptor ID |
D018078
|
| MeSH Number(s) |
D12.776.543.750.695.200.700.600
|
| Concept/Terms |
Receptors, Prostaglandin E- Receptors, Prostaglandin E
- Prostaglandin E Receptors
- E Receptors, Prostaglandin
- PGE2 Receptors
- PGE Receptor
- PGE Receptors
- Prostaglandin E Receptor
- E Receptor, Prostaglandin
- Receptor, Prostaglandin E
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Prostaglandin E".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Prostaglandin E".
This graph shows the total number of publications written about "Receptors, Prostaglandin E" by people in this website by year, and whether "Receptors, Prostaglandin E" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 2 | 0 | 2 |
| 2003 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Prostaglandin E" by people in Profiles.
-
Prostaglandin receptors EP and FP are regulated by estradiol and progesterone in the uterus of ovariectomized rats. Reprod Biol Endocrinol. 2012 Jan 18; 10:3.
-
Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4. Cancer. 2010 Jun 01; 116(11 Suppl):2806-14.
-
Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells. J Exp Ther Oncol. 2008; 7(4):299-312.